Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ONYX PHARMACEUTICALS INC | 65,904 | reported | 14 Oct 2011 | tx 87+848,000−508,334 |
| ANGIOTECH PHARMACEUTICALS INC | 42,500 | reported | 10 Dec 2009 | tx 4+27,500 |
| Edgewise Therapeutics, Inc. | 30,000 | reported | 16 Jun 2025 | tx 4+114,804 |
| Pacira BioSciences, Inc. | 23,715 | reported | 11 Jun 2025 | tx 42+176,495−61,700 |
| Mirum Pharmaceuticals, Inc. | 17,194 | reported | 11 Sept 2025 | tx 16+139,597−39,703 |
| ACADIA PHARMACEUTICALS INC | 16,004 | reported | 29 May 2026 | tx 79+653,602−480,204 |
| DYNAVAX TECHNOLOGIES CORP | 15,000 | reported | 30 May 2019 | tx 7+55,675−2,000 |
| DELCATH SYSTEMS, INC. | 11,678 | reported | 07 Jul 2014 | tx 3+97,202 |
| ARATANA THERAPEUTICS, INC. | 7,500 | reported | 27 Jul 2018 | tx 8+59,237 |
| PORTOLA PHARMACEUTICALS INC | 0 | reported | 02 Jul 2020 | tx 15+76,843−76,843 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | — | |
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 16,004 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,311 | 0.00 USD | deriv |
| 11 Sept 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 17,000 | 15.00 USD | |
| 11 Sept 2025 | SALE | Mirum Pharmaceuticals, Inc. | 1,491 | 75.07 USD | |
| 11 Sept 2025 | SALE | Mirum Pharmaceuticals, Inc. | 15,509 | 74.34 USD | |
| 11 Sept 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 17,000 | 0.00 USD | deriv |
| 16 Jun 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Pacira BioSciences, Inc. | 6,163 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Pacira BioSciences, Inc. | 11,279 | 0.00 USD | deriv |
| 04 Jun 2025 | SALE | ACADIA PHARMACEUTICALS INC | 14,446 | 21.78 USD | |
| 29 May 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 5,703 | — | |
| 29 May 2025 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 3,977 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 6,268 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | Mirum Pharmaceuticals, Inc. | 5,703 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | — | |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 13,793 | 0.00 USD | deriv |
| 16 Aug 2024 | PURCHASE | Pacira BioSciences, Inc. | 1,000 | 12.81 USD | first after silence |
| 12 Jun 2024 | GRANT_AWARD | Pacira BioSciences, Inc. | 5,230 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Pacira BioSciences, Inc. | 12,179 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 20,594 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Mirum Pharmaceuticals, Inc. | 5,703 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 Aug 2024.